Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3290278
Max Phase: Preclinical
Molecular Formula: C25H37N3O4
Molecular Weight: 443.59
Molecule Type: Small molecule
Associated Items:
ID: ALA3290278
Max Phase: Preclinical
Molecular Formula: C25H37N3O4
Molecular Weight: 443.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)CCO[C@@H]1C=CC(=O)[C@@H](Cn2cc(COCC34CC5CC(CC(C5)C3)C4)nn2)O1
Standard InChI: InChI=1S/C25H37N3O4/c1-17(2)5-6-31-24-4-3-22(29)23(32-24)14-28-13-21(26-27-28)15-30-16-25-10-18-7-19(11-25)9-20(8-18)12-25/h3-4,13,17-20,23-24H,5-12,14-16H2,1-2H3/t18?,19?,20?,23-,24+,25?/m1/s1
Standard InChI Key: FTKLQKPBDWVNOK-OUOOCPCMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 443.59 | Molecular Weight (Monoisotopic): 443.2784 | AlogP: 3.92 | #Rotatable Bonds: 10 |
Polar Surface Area: 75.47 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.65 | CX LogD: 4.65 |
Aromatic Rings: 1 | Heavy Atoms: 32 | QED Weighted: 0.55 | Np Likeness Score: -0.17 |
1. Sharma S, Saquib M, Verma S, Mishra NN, Shukla PK, Srivastava R, Prabhakar YS, Shaw AK.. (2014) Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents., 83 [PMID:24992075] [10.1016/j.ejmech.2014.06.048] |
Source(1):